ctrl K

Watchlist Price Alert

TScan Therapeutics Inc. (TCRX)

NASDAQ: TCRX · Real-Time Price · USD

1.31

0.03 (2.34%)

At close: May 15, 2025, 2:32 PM

TScan Therapeutics Revenue Breakdown

Period Ending	Dec 31, 2024
Reportable Segment Revenue	2.82M
Reportable Segment Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	8.46M	7.29M	7.41M	7.77M	7.08M	4.88M	5.89M	6.53M	7.77M	6.14M	4.91M	4.81M	4.49M	4.45M	4.05M	2.73M	2.61M	2.64M	1.65M	1.11M	1.34M
Selling, General, and Administrative Revenue Growth	+15.93%	-1.54%	-4.68%	+9.76%	+45.06%	-17.17%	-9.75%	-15.91%	+26.50%	+25.05%	+2.12%	+6.99%	+1.03%	+9.88%	+48.50%	+4.60%	-1.33%	+60.25%	+47.94%	-16.74%	n/a
Research and Development Revenue	29.79M	29.35M	26.26M	26.88M	24.86M	22.41M	22.74M	21.23M	21.78M	15.6M	15.03M	14.49M	14.69M	12.61M	14.21M	10.8M	7.34M	5.96M	5.81M	4.5M	4.3M
Research and Development Revenue Growth	+1.48%	+11.77%	-2.29%	+8.13%	+10.94%	-1.47%	+7.13%	-2.53%	+39.57%	+3.81%	+3.70%	-1.33%	+16.51%	-11.25%	+31.52%	+47.17%	+23.05%	+2.60%	+29.12%	+4.75%	n/a